Search research articles
Contact Us
Filters
Showing results (71-80 of 178) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2008
Small-cell carcinoma of the prostate
Christopher J Anker, Christopher Dechet, Jorge C Isaac, et al.
JAMA
|
January 26, 2006
Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma
Christopher M Lee, Aniko Szabo, Dennis C Shrieve, et al.
Urologic Oncology
|
May 3, 2008
Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database
O Kenneth Macdonald, Anthony V D'Amico, Natalia Sadetsky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2008
Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients
Ying J Hitchcock, Jonathan D Tward, Aniko Szabo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 22, 2016
Time Course and Accumulated Risk of Severe Urinary Adverse Events After High- Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy
Jonathan D Tward, Stephanie Jarosek, Haitao Chu, et al.
Urology
|
July 28, 2007
Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database
O Kenneth Macdonald, Anthony V D'Amico, Natalia Sadetsky, et al.
Cureus
|
December 3, 2016
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma Resulting in a Durable Relapse-Free Survival: A Case Report
Samual Francis, Ned Williams, Christopher J Anker, et al.
Cancer Research
|
April 6, 2001
A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck
E Hanna, D C Shrieve, V Ratanatharathorn, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 22, 2007
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer
Aaron P Brown, Jergin Chen, Ying J Hitchcock, et al.
Cancer
|
May 19, 2006
The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
Jonathan D Tward, Merideth M M Wendland, Dennis C Shrieve, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 178) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2008
Small-cell carcinoma of the prostate
Christopher J Anker, Christopher Dechet, Jorge C Isaac, et al.
JAMA
|
January 26, 2006
Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma
Christopher M Lee, Aniko Szabo, Dennis C Shrieve, et al.
Urologic Oncology
|
May 3, 2008
Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database
O Kenneth Macdonald, Anthony V D'Amico, Natalia Sadetsky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2008
Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients
Ying J Hitchcock, Jonathan D Tward, Aniko Szabo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 22, 2016
Time Course and Accumulated Risk of Severe Urinary Adverse Events After High- Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy
Jonathan D Tward, Stephanie Jarosek, Haitao Chu, et al.
Urology
|
July 28, 2007
Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database
O Kenneth Macdonald, Anthony V D'Amico, Natalia Sadetsky, et al.
Cureus
|
December 3, 2016
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma Resulting in a Durable Relapse-Free Survival: A Case Report
Samual Francis, Ned Williams, Christopher J Anker, et al.
Cancer Research
|
April 6, 2001
A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck
E Hanna, D C Shrieve, V Ratanatharathorn, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 22, 2007
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer
Aaron P Brown, Jergin Chen, Ying J Hitchcock, et al.
Cancer
|
May 19, 2006
The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
Jonathan D Tward, Merideth M M Wendland, Dennis C Shrieve, et al.
Page
of 18